title: Who owns CRISPR-Cas9 in Europe?
abstract: Recent developments in the prosecution of the CRISPR-Cas9 patent in Europe highlight the differences between the intellectual property regimes of Europe and the United States.
authors.affiliation: Kupecz Intellectual Property, Amsterdam, the Netherlands.
authors.forename: András
authors.initials: A
authors.lastname: Kupecz
mesh_terms: D064113:CRISPR-Cas Systems; D005060:Europe; D015894:Genome, Human; D006801:Humans; D018973:Intellectual Property; D010330:Patents as Topic; D014481:United States